OncoSec Medical Inc (ONCSQ)

[$Moneypenny$]

1. Pegs: http://www.pegsummit.com/Cancer-Antibodies/

11:10 Glass Half-Empty or Half-Full? Potential Mechanisms of Non-Response to Immunomodulatory Antibodies
PiearceABCRobert H. Pierce, M.D., CMO, OncoSec Medical, Inc.

2. EADO: http://www.eado2014.com/user/_files/30/Program%202014-04-03.pdf

ImmunePulse phase II study
Axel Hauschild (Kiel, DE)

3. Boston Biotech Cancer Advance: http://bbbiotechconference.com/conference-agenda.php?id=23

4:40 PM-5:20 PM Cancer in 15 Years: Predictions
Punit Dhillon, OncoSec; Ferran Prat, MD Anderson Cancer Center; Robert Wild, Eli Lilly; Krishna Yeshwant, Google Ventures
Moderator: Ashley Dombkowski, Bay City Capital

4. ASGCT 17th Annual Meeting: http://asgct.execinc.com/edibo/AM14FullSchedule

Richard Heller, PhD
Non-Viral Gene Transfer of pIL-12 for the Treatment of Melanoma: Results from Phase I and II Clinical Trials
Electrotransfer of plasmids encoding cytokines directly to tumors has been shown to generate a local and systemic anti-tumor effect in both preclinical and clinical studies. In the clinical studies, patients with in-transit cutaneous melanoma received at least one treatment cycle (days 1, 5, 8) of intratumor pIL-12 delivered by electrotransfer in up to four lesions per cycle. In both the Phase I and II trials increases in IL-12 levels and enhanced immune activity were observed and the therapy was well tolerated. Intratumor treatment with pIL-12 electro transfer exhibited a systemic antitumor immune response with activity in both treated and non-treated sites of disease and objective response to treatment. These positive results provide the rationale for an expanded study.

5. ASCO 59th Annual Meeting: http://ir.stockpr.com/oncosec/company-news/detail/1344/oncosec-medical-selected-to-present-phase-ii-data-in-poster-highlights-session-at-2014-asco-annual-meeting

6. Marcum Conference: http://www.marcumllp.com/MicroCap/presenting-companies

The Marcum MicroCap Conference is dedicated to introducing investors to the very best, undiscovered companies under $500 million in market capitalization. Launched in 2012, the annual Marcum MicroCap Conference features presentations by CEOs and CFOs from promising high-growth companies, the top picks by some of the most astute analysts following small caps, and thoughtful commentary on successful investment strategies and sectors. Marcum is again partnering with KCSA Strategic Communications and Launchpad Investor Relations to host the conference in its third year.

This invitation-only event attracts top fund managers and qualified high net worth investors who focus on small cap equities. One-on-one meetings are available for company management teams and qualified investors.

7. ACS Blossom Ball: http://localwiki.net/yuba-sutter/American_Cancer_Society_Blossom_Ball

American Cancer Society Announces Blossom Ball Event, Sunset in the Buttes • May 31, 2014

The fifth annual American Cancer Society (ACS) Blossom Ball fundraiser is quickly becoming the most exciting and elegant event in our community. This year’s outdoor black-tie event will feature gourmet dining, live entertainment, dancing under the stars and an appealing array of items in both live and silent auctions. Last year’s successful inaugural event, which was attended by over 400 people, raised more than $105,000 for the fight against cancer.

This year’s Blossom Ball will be held on Saturday, May 31, from 6 pm until 12 midnight, at the Southridge Golf Club, 9413 South Butte Road, Sutter, California 95982. Tickets are $100 each, with proceeds going to support ACS programs, patient services and cancer research.